While the BRCA2 mutation is best known for its associated elevated breast and ovarian cancer risk, it also conveys an increased risk of pancreatic adenocarcinoma (PAC) as the most common genetic alteration found in familial pancreatic cancer. This evidence concerns the gene BRCA2 and pancreatic neoplasm.